Hydroxystilbamidine

CHEMBL1301 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

280.3 g/mol

LogP

1.8

Phase

4

An antifungal agent used to treat certain serious fungal infections, particularly blastomycosis. It works by disrupting the cell membranes of the fungus.

Moleküler Ağırlık

280,3200 g/mol

LogP

1,80

TPSA

120,00 Å²

Lipinski RO5

Geçer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

N=C(N)c1ccc(/C=C/c2ccc(C(=N)N)cc2O)cc1

InChI

InChI=1S/C16H16N4O/c17-15(18)12-5-2-10(3-6-12)1-4-11-7-8-13(16(19)20)9-14(11)21/h1-9,21H,(H3,17,18)(H3,19,20)/b4-1+

Molecular Formula

C16H16N4O

HBD / HBA

5 / 3

Döndürülebilir Bağlar

4

Ağır Atomlar

21

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

An antifungal agent used to treat certain serious fungal infections, particularly blastomycosis. It works by disrupting the cell membranes of the fungus.

Yes, Hydroxystilbamidine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1301. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 5284571. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Hydroxystilbamidine PillFYI'da

Yapı

Hızlı Veriler

Formül: C16H16N4O

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.